Cardiology Research and Practice / 2019 / Article / Tab 5

Research Article

Resting Heart Rate and Long-Term Outcomes in Patients with Percutaneous Coronary Intervention: Results from a 10-Year Follow-Up of the CORFCHD-PCI Study

Table 5

Multivariable Cox regression analysis of MACEs.

VariablesBSEWald valueHR (95% CI)

Age−0.0010.0040.1530.6960.999 (0.991–1.006)
SBP−0.0020.0020.8340.3610.998 (0.993–1.003)
DBP0.0030.0040.3730.5411.003 (0.994–1.011)
Diabetes0.1620.0903.2460.0721.176 (0.986–1.402)
Hypertension0.2910.08212.5650.0001.338 (1.139–1.572)
ML0.2490.0897.8600.0051.283 (1.078–1.527)
CTO0.3110.08912.2320.0001.364 (1.146–1.624)
Aspirin−0.5510.09037.7200.0000.577 (0.484–0.687)
Statins−0.0080.0950.0070.9340.992 (0.824–1.195)
β-Blockers−0.0860.0920.8690.3510.918 (0.766–1.099)
LVEDD−0.0130.0082.6740.1020.987 (0.972–1.003)
LVEF−0.0060.0060.8780.3490.994 (0.982–1.006)
Heart rate (<66 beats/min as reference)14.7980.005
 66–72 beats/min−0.0150.1350.0120.9130.985 (0.756–1.284)
 72–78 beats/min−0.0570.1230.2120.6460.945 (0.742–1.203)
 78–84 beats/min0.2270.1213.5320.0601.255 (0.990–1.590)
 ≥84 beats/min0.3090.1226.3650.0121.361 (1.071–1.730)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.